APP Pharma To Commercialise Liquid Oxaliplatin Injection In US
FDA granted approval to market Oxaliplatin Injection in two dosage strengths to Fresenius Kabi Oncology. Oxaliplatin injection is therapeutically equivalent to Eloxatin, which is invented and marketed by
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.